Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
ConditionAortic Valve Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorHemoCept Inc.
About this trial
The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
Eligibility criteria
Qualifiers
Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
Subjects can be any gender but must be between (and including) the ages of 18 and 80.
Subject ls being treated by the participating healthcare facility .
Subject is able and willing to provide informed consent and HIPM authorization.
Disqualifiers
Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
Long O-T syndrome
Cardiac channelopathies
Seizures
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Boulder Heart80303, BoulderColorado, United States
Sponsors and collaborators
HemoCept Inc.
Lead sponsor
Source ClinicalTrials.gov